The effect of subcapsular meningococcal B + C vaccine on the prognosis of patients with meningococcal disease

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 6, 2002, Pages 417-420

  Barroso, David E ^a   Carvalho, Diana M ^a   Netto, Marco A C ^a   Santos, Otília H L R ^a   Nascimento, Fábio A ^a   Werneck, Guilherme L ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MENINGOCOCCUS VACCINE; VAMENGOC B + C;

AGE; ARTICLE; BRAZIL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FATALITY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MORTALITY; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; INCIDENCE; STATISTICAL MODEL;

BRAZIL; CHILD, PRESCHOOL; FEMALE; HUMAN; INCIDENCE; INFANT; LOGISTIC MODELS; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0035990584     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110080322     Document Type: Article

References (18)

1. Meningococcal disease: Public health burden and control
2. Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex
3. Epidemiology and molecular analysis of epidemic meningococcal disease related to group C Neisseria meningitidis in a Brazilian metropolis: Rio de Janeiro, 1993-1995
4. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: Effect of immunization with an outer membrane protein vaccine
5. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: A case-control study
6. Meningococcal vaccines: Current status
7. Meningococcal vaccines: Past, present and future
8. Prophylaxis of bacterial meningitis
9. Efficacy evaluation of the Cuban vaccine VA-MENGOC-BC against disease caused by sergroup B Neisseria meningitidis
10. Effect of outer membrane vesicle vaccine against serogroup B meningococcal disease in Norway
11. Efficacy, safety, and immunogenicity of a meningococcal group B (B:15:P1.3) outer membrane protein vaccine in Iquique, Chile
12. Vaccine against group B Neisseria meningitidis: Protection trial and mass vaccination results in Cuba
13. Avaliação da proteção conferida pela vacina antimeningocócica BC no Estado de Santa Catarina, Brasil, 1990/92
14. Protective efficacy of a serogroup B meningoccocal vaccine in São Paulo, Brazil
15. Epidemic of meningococcal meningitis in Bamako, Mali: Epidemiological features and analysis of vaccine efficacy
16. Evaluation of human antibody response to Neisseria meningitidis C invasive disease using different immunological assays. Standardisation and validation of serologic assays for the evaluation of immune response meningitidis serogroup A/C vaccines
17. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial
18. Benign meningococcemia with IgG and IgM antimeningococcal antibodies measured by ELISA